Browsing by Title

Now showing items 80080-80099 of 106134

S-acylation stabilizes ligand-induced receptor kinase complex formation during plant pattern-triggered immune signaling

Xhelilaj, Kaltra; Gronnier, Julien (2023)
S-Bahn-Ethnologie : acht Bemerkungen zum Berliner Alltag nach Öffnung der Mauer

Korff, Gottfried (2013)
s-Triazin-anellierte Ligandensysteme : Synthese und Metallkomplexe

Buck, Dominik (2015)
S. Antioco (Sardinia, Italy) : "Sulci: progetto Tofet" : first remarks on archaeometrical analyses of pottery (2015-2017)

Melchiorri, Valentina (2020)
S.T.A.R.-Track: Latent Motion Models for End-to-End 3D Object Tracking with Adaptive Spatio-Temporal Appearance Representations

Lensch, Hendrik P. A.; Hanselmann, Niklas; Schulz, Richard (2023-06-30)
S/T Phosphorylation of DLL1 Is Required for Full Ligand Activity In Vitro but Dispensable for DLL1 Function In Vivo during Embryonic Patterning and Marginal Zone B Cell Development

Madlung, Johannes; Maček, Boris (2014)
S1 guideline: microscopically controlled surgery (MCS)

Häfner, Hans-Martin; Breuninger, Helmut (2015)
S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018

Breuninger, Helmut; Garbe, Claus (2019)
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)

Leiter, Ulrike (2022)
S1-Guideline: Management of Late-term and Post-term Pregnancy Short version* - AWMF Registry Number: 015/065

Abele, Harald (2014)
S1-Guidelines on UV phototherapy and photochemotherapy

Ghoreschi, Kamran; Röcken, Martin (2016)
S1-Leitlinie: Mikroskopisch kontrollierte Chirurgie

Kofler, Lukas (2022)
S100B als Marker für Lewy-Körper-Erkrankungen : eine Fall-Kontroll-Studie mit Bestimmung von Einzelbasen-Polymorphismen und Serum- und Liquorwerten

Lang, Johannes Dominik (2014)
S100B als Marker für Lewy-Körper-Erkrankungen: Eine Fall-Kontroll-Studie mit Bestimmung von Einzelbasen-Polymorphismen und Serum- und Liquorwerten

Lang, Johannes Dominik (2014)

Ziel der vorgelegten Arbeit war es, S100B-Konzentrationen in Liquor und Serum auf Unterschiede bei Patienten mit Lewy-Körper-Erkrankung (LBD) und Kontrollpersonen zu untersuchen. Desweiteren sollte eine Analyse von zwei ...
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma

Abusaif, Sail Nawaf Rashid; Jradi, Zeinab; Held, Laura; Pflugfelder, Annette Dorothee; Weide, Benjamin Matthias; Meier, Friedegund; Garbe, Claus; Eigentler, Thomas (2013)
S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies

Wagner, Nikolaus B.; Forschner, Andrea Lydia; Leiter-Stöppke, Ulrike; Garbe, Claus; Eigentler, Thomas (2018)
S100B and LDH as parameters to monitor the clinical course of patients with advanced melanoma treated with Vemurafenib

Abusaif, Sail Nawaf Rashid (2016)
S100B and LDH as parameters to monitor the clinical course of patients with advanced melanoma treated with Vemurafenib

Abusaif, Sail Nawaf Rashid (2016-12)

Vemurafenib is a highly efficient BRAF inhibitor for metastatic melanoma patients carrying the V600 mutation. Progression free survival is prolonged to approximately 6 months and 50 to 80% of the patients show objective ...
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway

Maetzler, Walter; Lang, Johannes Dominik; Schulte, Claudia; Synofzik, Matthis; Berg, Daniela (2012)
S1‐Leitlinie Tinea capitis

Schaller, Martin (2020)

Now showing items 80080-80099 of 106134

Submit

Browse

All of DSpace

Browsing by Title

Browsing by Title

Browse

All of DSpace

My Account

Hilfe & Infos